Summary of the invention
Research worker is surprisingly found, while preparing the mix suspension grain of calcitriol and calcium carbonate, the meglumine adding in right amount, PEG400 and polyethylene glycol 6000, can significantly improve content, stability and the bioavailability of calcitriol in preparation, thereby can reduce the consumption of calcium carbonate, so there is unforeseeable technique effect, significant for the clinical use of medicine.
The invention provides a kind of active component content is high, medicine stability good, bioavailability is high calcitriol and the mix suspension grain of calcium carbonate.This mix suspension grain is made by the component of following percentage by weight:
Calcitriol 0.0005%
Calcium carbonate 5-10%
Meglumine 2.0-4.0%
PEG400 1.2-1.8%
Polyethylene glycol 6000 12-18%
Filler 45-75%
Disintegrating agent 5.0-10.0%
Binding agent is appropriate.
Its optimizing prescriptions is:
Calcitriol 0.0005%
Calcium carbonate 8.0%
Meglumine 3.0%
PEG400 1.5%
Polyethylene glycol 6000 15%
Filler 60%
Disintegrating agent 8.0%
Binding agent is appropriate.
Further, above-mentioned filler is selected from one or more in starch, lactose, dextrin, amylum pregelatinisatum and Icing Sugar.
Further, above-mentioned disintegrating agent is selected from one or more in carboxymethyl starch sodium, low-substituted hydroxypropyl cellulose, microcrystalline Cellulose, cross-linking sodium carboxymethyl cellulose and sodium alginate.
Further, above-mentioned binding agent is selected from one or more in starch, pregelatinized Starch, hyprolose, hypromellose and polyvidone.
The preparation method of this mix suspension grain is:
1) take the supplementary material of recipe quantity, cross respectively 80-120 mesh sieve standby;
2) binding agent of getting after sieving adds distilled water, makes binder solution;
3) by the calcitriol after sieving, calcium carbonate, meglumine, PEG400, polyethylene glycol 6000, filler and disintegrating agent by equivalent incremental method mix homogeneously, add above-mentioned binder solution to make soft material;
4), after granulating with 40 mesh sieves, dry 30-60min at 50-70 ℃, crosses 20 mesh sieve granulate; After No. 4 sieve sieves, remove fine powder, subpackage, sealing, packing and get final product.
The preparation method of this mix suspension grain is more preferably:
1) take the supplementary material of recipe quantity, cross respectively 100 mesh sieves standby;
2) binding agent of getting after sieving adds distilled water, makes binder solution;
3) by the calcitriol after sieving, calcium carbonate, meglumine, PEG400, polyethylene glycol 6000, filler and disintegrating agent by equivalent incremental method mix homogeneously, add above-mentioned binder solution to make soft material;
4) after granulating with 40 mesh sieves, dry 45min at 60 ℃, crosses 20 mesh sieve granulate, after No. 4 sieve sieves, removes fine powder, subpackage, sealing, packing and get final product.
The invention has the beneficial effects as follows:
1. in said preparation, the content of calcitriol significantly increases, and has reduced the dose of medicine;
2. improved the stability of calcitriol to light, air having added of meglumine, PEG400 and polyethylene glycol 6000, its bioavailability is also significantly improved, thereby has reduced the consumption of calcium carbonate in compositions.
The specific embodiment
Below in conjunction with concrete embodiment, technical scheme of the present invention is further described.
The mix suspension grain of embodiment 1 calcitriol and calcium carbonate
Prescription is:
Calcitriol 1.5mg
Calcium carbonate 15g
Meglumine 6.0g
PEG400 3.6g
Polyethylene glycol 6000 36g
Starch 210g
Carboxymethyl starch sodium 15g
Pregelatinized Starch is appropriate.
Preparation method is:
1) take the supplementary material of recipe quantity, cross respectively 80 mesh sieves standby;
2) pregelatinized Starch of getting after sieving adds distilled water, makes binder solution;
3) by the calcitriol after sieving, calcium carbonate, meglumine, PEG400, polyethylene glycol 6000, starch and carboxymethyl starch sodium by equivalent incremental method mix homogeneously, add above-mentioned binder solution to make soft material;
4) after granulating with 40 mesh sieves, dry 30min at 50 ℃, crosses 20 mesh sieve granulate, after No. 4 sieve sieves, removes fine powder, subpackage, sealing, packing and get final product.
The mix suspension grain of embodiment 2 calcitriols and calcium carbonate
Prescription is:
Calcitriol 1.5mg
Calcium carbonate 30g
Meglumine 12g
PEG400 5.4g
Polyethylene glycol 6000 54g
Lactose 150g
Low-substituted hydroxypropyl cellulose 30g
Hyprolose is appropriate.
Preparation method is:
1) take the supplementary material of recipe quantity, cross respectively 120 mesh sieves standby;
2) hyprolose of getting after sieving adds distilled water, makes binder solution;
3) by the calcitriol after sieving, calcium carbonate, meglumine, PEG400, polyethylene glycol 6000, lactose and low-substituted hydroxypropyl cellulose by equivalent incremental method mix homogeneously, add above-mentioned binder solution to make soft material;
4) after granulating with 40 mesh sieves, dry 60min at 70 ℃, crosses 20 mesh sieve granulate, after No. 4 sieve sieves, removes fine powder, subpackage, sealing, packing and get final product.
The mix suspension grain of embodiment 3 calcitriols and calcium carbonate
Prescription is:
Calcitriol 1.5mg
Calcium carbonate 24g
Meglumine 9.0g
PEG400 4.5g
Polyethylene glycol 6000 45g
Dextrin 180g
Microcrystalline Cellulose 24.0g
Polyvidone is appropriate.
Preparation method is:
1) take the supplementary material of recipe quantity, cross respectively 100 mesh sieves standby;
2) polyvidone of getting after sieving adds distilled water, makes binder solution;
3) by the calcitriol after sieving, calcium carbonate, meglumine, PEG400, polyethylene glycol 6000, dextrin and microcrystalline Cellulose by equivalent incremental method mix homogeneously, add above-mentioned binder solution to make soft material;
4) after granulating with 40 mesh sieves, dry 45min at 60 ℃, crosses 20 mesh sieve granulate, after No. 4 sieve sieves, removes fine powder, subpackage, sealing, packing and get final product.
The mix suspension grain of comparing embodiment 1 calcitriol and calcium carbonate
Calcitriol 1.5mg
Calcium carbonate 24g
PEG400 4.5g
Polyethylene glycol 6000 45g
Dextrin 180g
Microcrystalline Cellulose 24.0g
Polyvidone is appropriate.
Preparation method is same embodiment 3:
The mix suspension grain of comparing embodiment 2 calcitriols and calcium carbonate
Calcitriol 1.5mg
Calcium carbonate 24g
Meglumine 9.0g
Polyethylene glycol 6000 45g
Dextrin 180g
Microcrystalline Cellulose 24.0g
Polyvidone is appropriate.
Preparation method is with embodiment 3.
The mix suspension grain of comparing embodiment 3 calcitriols and calcium carbonate
Calcitriol 1.5mg
Calcium carbonate 24g
Meglumine 9.0g
PEG400 4.5g
Dextrin 180g
Microcrystalline Cellulose 24.0g
Polyvidone is appropriate.
Preparation method is with embodiment 3.
Embodiment 4 stability experiments and result
1. accelerated stability test
Intensity of illumination 4500lx, adopted HPLC method to carry out assay in the 0th, 5 and 10 days after timing sampling.
The condition of HPLC is: chromatographic column: ODS-C18 post, take octadecylsilane chemically bonded silica as filler; Mobile phase: acetonitrile-water (75:25); Detect wavelength: 265nm; Flow velocity: 1.0mL/min; Sample size: 50 μ L.Theoretical cam curve is pressed the calculating of calcitriol peak should be not low by 5000, and calcitriol peak and the peak-to-peak separating degree of trans calcitriol should be greater than 1.0.Adopt external standard method to calculate content.Assay result (percentage ratio of the amount of recording and labelled amount) sees the following form 1.Result shows that the stability of active component calcitriol in the mix suspension grain of calcitriol of the present invention and calcium carbonate is obviously better than comparative example.
Table 1 accelerated stability test assay result (%)
2. long-term stable experiment
25 ℃ of temperature, relative humidity are placed 36 months for 60% time, respectively at 0,3,6,12,24 and 36 months time sampling adopt HPLC method to carry out assay.The same accelerated stability test of condition of HPLC.Adopt external standard method to calculate content.Assay result (percentage ratio of the amount of recording and labelled amount) sees the following form 2.Result shows that the stability of active component calcitriol in the mix suspension grain of calcitriol of the present invention and calcium carbonate is obviously better than comparative example.
Table 2 long-term stable experiment assay result (%)
The comparative test of embodiment 5 bioavailability
4 beasle dogs (being male) are carried out to oral administration, they are fed respectively with the embodiment of the present invention 3, comparative example 1, comparative example 2, comparative example 3 calcitriol and the mix suspension grain of calcium carbonate (25 ℃ of temperature, relative humidity are placed 12 months for 60% time), dosage is 5.0 μ g/ only (in calcitriol), and be 7 days the interval time of each administration.Give after medicine, blood sample collection under different time, and carry out the maximum haemoconcentration (C of calcitriol
max) and bioavailability (AUC
0 → 48) calculating.Acquisition time is 0h, 0.25h, 0.5h, 1h, 2h, 4h, 6h, 8h, 12h, 24h, 32h, 48h.
Following table 3 provides the average result that 4 beasle dogs is given to the embodiment of the present invention 3, comparative example 1, comparative example 2, comparative example's 3 calcitriol and the mix suspension grain gained of calcium carbonate.As seen from table, the maximum haemoconcentration of the calcitriol of the mix suspension grain of calcitriol of the present invention and calcium carbonate (embodiment 3) and bioavailability are apparently higher than comparative example.
The comparison of table 3 bioavailability (5.0 μ g, n=3)
Should be noted that; the foregoing is only preferred embodiment of the present invention; be not limited to scope of the present invention, every any modification of having done within the spirit and principles in the present invention, the replacement being equal to and improvement etc., within all should being included in protection scope of the present invention.